SCOTT MOULTON: Open Payments
NPI 1710040761 · ARLINGTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$368 in 21 payments from 8 companies in 2025. Trend: 2023 $166 · 2024 $45 · 2025 $368
Food & beverage: $368
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $103 |
| Exact Sciences Corporation | 3 | $57 |
| Lilly USA, LLC | 3 | $53 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $50 |
| Novo Nordisk Inc | 2 | $41 |
| Avvisto Therapeutics, LLC | 2 | $33 |
| Dexcom, Inc. | 1 | $16 |
| PFIZER INC. | 1 | $15 |
Products named: The Cologuard Plus Collection Kit, QULIPTA, MOUNJARO, JARDIANCE, CYCLOSET, UBRELVY, Wegovy, SYNTHROID.
Industry payments across TX — which companies pay providers there.
